-
公开(公告)号:US08487093B2
公开(公告)日:2013-07-16
申请号:US12812763
申请日:2009-01-15
申请人: Timothy A. Blizzard , Helen Chen , Candido Gude , Jeffrey D. Hermes , Jason Imbriglio , Seongkon Kim , Jane Y. Wu , Christopher J. Mortko , Ian Mangion , Nelo Rivera , Rebecca T. Ruck , Michael Shevlin
发明人: Timothy A. Blizzard , Helen Chen , Candido Gude , Jeffrey D. Hermes , Jason Imbriglio , Seongkon Kim , Jane Y. Wu , Christopher J. Mortko , Ian Mangion , Nelo Rivera , Rebecca T. Ruck , Michael Shevlin
IPC分类号: C07D243/00 , A61K31/551
CPC分类号: C07D471/08 , C07D211/58 , C07D211/60 , C07D211/78 , C07D487/08 , C07D519/00
摘要: Substituted bicyclic beta-lactams of Formula I: (I), are β-lactamase inhibitors, wherein a, X, R1 and R2 are defined herein. The compounds and pharmaceutically acceptable salts thereof are useful in the treatment of bacterial infections in combination with β-lactam antibiotics. In particular, the compounds can be employed with a β-lactam antibiotics (e.g., imipenem, piperacillin, or ceftazidime) against microorganisms resistant to β-lactam antibiotics due to the presence of the β-lactamases.
摘要翻译: 式I的取代的双环β-内酰胺:(I)是β-内酰胺酶抑制剂,其中a,X,R 1和R 2在本文中定义。 化合物及其药学上可接受的盐可用于与β-内酰胺抗生素联合治疗细菌感染。 特别地,由于β-内酰胺酶的存在,该化合物可与β-内酰胺抗生素(例如亚胺培南,哌拉西林或头孢他啶)一起用于抗β-内酰胺抗生素的微生物。
-
公开(公告)号:US20110294777A1
公开(公告)日:2011-12-01
申请号:US12812763
申请日:2009-01-15
申请人: Timothy A. Blizzard , Helen Chen , Candido Gude , Jeffrey D. Hermes , Jason Imbriglio , Seongkon Kim , Jane Y. Wu , Sookhee Ha , Christopher J. Mortko , Ian Mangion , Nelo Rivera , Rebecca T. Ruck , Michael Shevlin
发明人: Timothy A. Blizzard , Helen Chen , Candido Gude , Jeffrey D. Hermes , Jason Imbriglio , Seongkon Kim , Jane Y. Wu , Sookhee Ha , Christopher J. Mortko , Ian Mangion , Nelo Rivera , Rebecca T. Ruck , Michael Shevlin
IPC分类号: A61K31/4545 , C07D487/08 , C07D519/00 , A61K31/55 , A61K31/454 , A61P31/04 , A61K31/439 , A61K31/553 , A61K31/496 , C07D401/12 , A61P31/00 , C07D471/08 , A61K31/4439
CPC分类号: C07D471/08 , C07D211/58 , C07D211/60 , C07D211/78 , C07D487/08 , C07D519/00
摘要: Substituted bicyclic beta-lactams of Formula I: (I), are β-lactamase inhibitors, wherein a, X, R1 and R2 are defined herein. The compounds and pharmaceutically acceptable salts thereof are useful in the treatment of bacterial infections in combination with β-lactam antibiotics. In particular, the compounds can be employed with a β-lactam antibiotics (e.g., imipenem, piperacillin, or ceftazidime) against microorganisms resistant to β-lactam antibiotics due to the presence of the β-lactamases.
摘要翻译: 式I的取代的双环β-内酰胺:(I)是β-内酰胺酶抑制剂,其中a,X,R 1和R 2在本文中定义。 化合物及其药学上可接受的盐可用于治疗与β-内酰胺抗生素组合的细菌感染。 特别地,由于β-内酰胺酶的存在,这些化合物可以与抗β-生物抗生素(例如亚胺培南,哌拉西林或头孢他啶)一起用于抗β-内酰胺抗生素的微生物。
-
公开(公告)号:US20100009957A1
公开(公告)日:2010-01-14
申请号:US12442816
申请日:2007-09-24
申请人: Timothy A. Blizzard , Helen Y. Chen , Jane Yang Wu , Seongkon Kim , Sookhee Ha , Christopher J. Mortko , Narayan Variankaval , Anna Chiu
发明人: Timothy A. Blizzard , Helen Y. Chen , Jane Yang Wu , Seongkon Kim , Sookhee Ha , Christopher J. Mortko , Narayan Variankaval , Anna Chiu
IPC分类号: A61K31/397 , C07D205/12 , A61P31/04
CPC分类号: C07D487/04
摘要: A class of 7-oxo-2,6-diazabicyclo-[3.2.0]-heptane-6-sulfonic acid compounds substituted at the two position of the bicyclic ring with a heterocyclylaminocarbonyl group or a carbocyclylaminocarbonyl group are β-lactamase inhibitors. The compounds and their prodrugs and pharmaceutically acceptable salts are useful in the treatment of bacterial infections in combination with β-lactam antibiotics. In particular, the compounds are suitable for use with β-lactam antibiotics (e.g., imipenem and ceftazidime) against micro-organisms resistant to β-lactam antibiotics due to the presence of the β-lactamases.
摘要翻译: 在双环的两个位置被杂环基氨基羰基或碳环基氨基羰基取代的一类7-氧代-2,6-二氮杂双环[3.2.0] - 庚烷-6-磺酸化合物是β-内酰胺酶抑制剂。 化合物及其前药和药学上可接受的盐可用于与β-内酰胺抗生素联合治疗细菌感染。 特别地,由于β-内酰胺酶的存在,这些化合物适用于β-内酰胺抗生素(例如亚胺培南和头孢他啶)对抗β-内酰胺抗生素的微生物。
-
-